Table 2 Information of 15 pathways
Term ID | Description | LogP | Count |
|---|---|---|---|
hsa05200 | Pathways in cancer | −26.20 | 32 |
hsa05418 | Fluid shear stress and atherosclerosis | −25.80 | 23 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | −19.57 | 17 |
hsa04659 | Th17 cell differentiation | −17.43 | 16 |
hsa04151 | PI3K-Akt signaling pathway | −16.96 | 23 |
hsa04657 | IL-17 signaling pathway | −16.88 | 15 |
hsa05215 | Prostate cancer | −14.23 | 13 |
hsa01522 | Endocrine resistance | −13.66 | 13 |
hsa04066 | HIF-1 signaling pathway | −13.36 | 13 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | −13.26 | 12 |
hsa04668 | TNF signaling pathway | −11.59 | 12 |
hsa04071 | Sphingolipid signaling pathway | −11.13 | 12 |
hsa04915 | Estrogen signaling pathway | −10.72 | 11 |
hsa04722 | Neurotrophin signaling pathway | −9.79 | 11 |
hsa05212 | Pancreatic cancer | −9.76 | 9 |